Close Menu

NEW YORK ─ Dante Labs, Cambridge Cancer Genomics (CCG.ai), and Nonacus said on Monday that they have inked a collaboration agreement to build a high-throughput cancer sequencing and interpretation service for tumor profiling that enables improved patient management, treatment, and monitoring.

The firms said that the service will combine Dante Labs’ experience and capacity in delivering a sequencing service for solid tumor and cell-free circulating tumor DNA from liquid biopsies with Nonacus’ targeted pan-cancer NGS libraries and CCG.ai’s AI-based software platform, OncOS.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

Apr
16
Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.